We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Buy pirates, short victims

23 July 2007 By Martin Hutchinson

The drop in Pfizer’s Lipitor sales is just one example. Patents aren’t what they used to be. IP protection in emerging markes is limited. With Doha dead, it won t improve. Investors should prefer the pirates over the IP owners.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)